What's happening
This bill directs the Department of Health to study the effects and diagnosis rates of ADHD medications in school-age children.
Why it matters
Focuses on safety and effectiveness. The bill requires a detailed study of not just how often ADHD and related medications are prescribed, but also their potential harmful side effects and whether current diagnostic tools and medication choices are appropriate for school-age children.
Addresses rising diagnosis rates. By examining the increasing rate of ADD/ADHD diagnoses, the study could spotlight whether more children are being labeled with these disorders and if current practices may be leading to over- or under-diagnosis.
Examines equity in healthcare. The legislation directs attention to demographic disparities, meaning it will look into whether certain groups of children (by race, socioeconomic status, etc.) are diagnosed or medicated differently, which could inform efforts to ensure fair treatment.
Informs future policy decisions. The mandated report to top state officials means the findings could drive future changes in state healthcare, education, or mental health policy, potentially affecting families, schools, and healthcare providers statewide.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Headline styles
Study ADHD Meds in Schools
Plain English, a few words. Used as the page title.
Sponsors
History
- Referred to health
- Referred to health
Companion bill
The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.
Study ADHD Drugs in Kids
In Senate Committee · Health · Sponsor Kevin S. Parker
Full text
1 pageUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
4527
2021-2022 Regular Sessions
IN ASSEMBLY
February 4, 2021
Introduced by M. of A. WALKER, JEAN-PIERRE, STECK, SANTABARBARA, COOK -read once and referred to the Committee on Health
AN ACT authorizing and directing the department of health to do research and study as to the effects of psychostimulants, selective seratonin reuptake inhibitors, antidepressants and other drugs which are prescribed for attention deficit disorders, ADD and ADHD, for school age children
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. 1. The commissioner of health, in conjunction with the commissioner of mental health, the commissioner of developmental disabilities, and the commissioner of education is authorized and directed to conduct a study and do research as to the effect of psychostimulants, selective serotonin reuptake inhibitors, antidepressants and other drugs prescribed for attention deficit disorder, attention deficit hyperactivity disorder, and the increasing rate of diagnosis of these conditions, in school age children.
2. The study shall be conducted in accordance with rules, regulations and standards determined by the commissioner of health, and the study shall concentrate on harmful side effects of such drugs, the appropriateness and effectiveness of tools and methods used to assess and diagnose the condition, the appropriateness of different medications, and any demographic disparities in diagnosis.
3. The commissioner of health shall report his or her findings to the governor, the speaker of the assembly and the temporary president of the senate on or before two years from the date this act shall take effect.
§ 2. This act shall take effect immediately.
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD07287-01-1
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.